This review focuses on the involvement of class I Myosins with cancer, in particular we will discuss the possible mechanisms by which myosins could contribute to cancer development and progression, particularly how Myo1g might enhance cellular motility and how this motility may promote the formation of infiltrates and increase the risk in diagnosed patients with ALL. Here, MYH14 is linked to acute lymphoblastic leukemia.